← Leaderboards
Sylvie Le Gall
Massachusetts General Hospital
$9,769,555
Attributed
$11,649,080
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$11,649,080 · 9
By mechanism
R01$9,433,356 · 4
R21$1,711,274 · 4
R56$504,450 · 1
Top collaborators
- Samuel M Behar4 shared
- Sarah M Fortune4 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Mathias Lichterfeld$34,368,889
- Kiera L. Clayton$3,881,475
- David E Fisher$28,420,496
- Stephanie Jost$7,411,250
- Galit Alter$32,273,423
Others in their field
Top investigators on “Immune Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,695,345
- Barton F Haynes · Duke University$456,664,915
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$309,708,725
- Peter B. Gilbert · Fred Hutchinson Cancer Center$192,329,665
Research focus
Immune ResponseCellsAntigensHiv InfectionsEpitopesPeptidesPatternProteinsDesignAntigen ProcessingT-LymphocyteProductionProtein DegradationVaccinesCd4 Positive T LymphocytesT Cell ResponseComputer AnalysisInfectionAreaLeadBiochemicalAffectVaccine DesignDendritic Cells
Grant awards (26)
Tuberculosis and T cell Recognition$690,876
R01 · FY2019 · AI
Identification of novel HIV-derived antigens$252,000
R21 · FY2019 · AI · contact PI
Tuberculosis and T cell Recognition$694,621
R01 · FY2018 · AI
The HLA-E peptidome in HIV infection$213,750
R21 · FY2018 · AI · contact PI
Unbiased identification of HIV-derived antigens during latency and reactivation$213,750
R21 · FY2018 · AI · contact PI
Tuberculosis and T cell Recognition$698,256
R01 · FY2017 · AI
Learning from attenuated CMV how to broaden HIV-specific T cell responses$581,842
R01 · FY2017 · AI · contact PI
The HLA-E peptidome in HIV infection$256,500
R21 · FY2017 · AI · contact PI
Unbiased identification of HIV-derived antigens during latency and reactivation$256,500
R21 · FY2017 · AI · contact PI
Tuberculosis and T cell Recognition$735,535
R01 · FY2016 · AI
Learning from attenuated CMV how to broaden HIV-specific T cell responses$555,742
R01 · FY2016 · AI · contact PI
Defining and matching epitope presentation in HIV infection and vaccination$504,450
R56 · FY2016 · AI · contact PI
Learning from attenuated CMV how to broaden HIV-specific T cell responses$548,782
R01 · FY2015 · AI · contact PI
Learning from attenuated CMV how to broaden HIV-specific T cell responses$531,382
R01 · FY2014 · AI · contact PI
Mechanisms and optimization of epitope presentation by HIV-infectable cell subset$407,673
R01 · FY2013 · AI · contact PI
Immune responses against HIV-induced cell-derived neoepitopes and HIV control$512,985
R01 · FY2012 · AI · contact PI
Mechanisms and optimization of epitope presentation by HIV-infectable cell subset$433,694
R01 · FY2012 · AI · contact PI
Immune responses against HIV-induced cell-derived neoepitopes and HIV control$513,192
R01 · FY2011 · AI · contact PI
Mechanisms and optimization of epitope presentation by HIV-infectable cell subset$433,694
R01 · FY2011 · AI · contact PI
Immune responses against HIV-induced cell-derived neoepitopes and HIV control$518,357
R01 · FY2010 · AI · contact PI
Mechanisms and optimization of epitope presentation by HIV-infectable cell subset$438,075
R01 · FY2010 · AI · contact PI
Mechanisms and optimization of epitope presentation by HIV-infectable cell subset$188,254
R01 · FY2010 · AI · contact PI
Immune responses against HIV-induced cell-derived neoepitopes and HIV control$508,105
R01 · FY2009 · AI · contact PI
Mechanisms and optimization of epitope presentation by HIV-infectable cell subset$442,291
R01 · FY2009 · AI · contact PI
Role of antigen processing HIV CTL immunodominance$262,500
R21 · FY2005 · AI
Role of antigen processing HIV CTL immunodominance$256,274
R21 · FY2004 · AI